nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—liver cancer—duodenum cancer	0.923	1	CtDrD
Sorafenib—ABCC2—bile duct—duodenum cancer	0.00481	0.0622	CbGeAlD
Sorafenib—ABCC2—bile—duodenum cancer	0.00369	0.0478	CbGeAlD
Sorafenib—CDKL3—endocrine gland—duodenum cancer	0.00242	0.0314	CbGeAlD
Sorafenib—CDKL2—endocrine gland—duodenum cancer	0.00222	0.0287	CbGeAlD
Sorafenib—MAPK15—endocrine gland—duodenum cancer	0.002	0.0258	CbGeAlD
Sorafenib—PDGFRA—gall bladder—duodenum cancer	0.0017	0.0221	CbGeAlD
Sorafenib—HIPK3—pancreas—duodenum cancer	0.0014	0.0181	CbGeAlD
Sorafenib—KIT—gall bladder—duodenum cancer	0.00136	0.0176	CbGeAlD
Sorafenib—HIPK4—endocrine gland—duodenum cancer	0.00134	0.0174	CbGeAlD
Sorafenib—PDGFRB—gall bladder—duodenum cancer	0.00133	0.0172	CbGeAlD
Sorafenib—ZAK—digestive system—duodenum cancer	0.00122	0.0158	CbGeAlD
Sorafenib—HIPK3—digestive system—duodenum cancer	0.00119	0.0154	CbGeAlD
Sorafenib—CDK7—endocrine gland—duodenum cancer	0.00116	0.0151	CbGeAlD
Sorafenib—AURKC—endocrine gland—duodenum cancer	0.00115	0.0148	CbGeAlD
Sorafenib—EPHA6—endocrine gland—duodenum cancer	0.00106	0.0137	CbGeAlD
Sorafenib—ZAK—endocrine gland—duodenum cancer	0.00101	0.013	CbGeAlD
Sorafenib—HIPK3—endocrine gland—duodenum cancer	0.000985	0.0128	CbGeAlD
Sorafenib—MKNK2—pancreas—duodenum cancer	0.000976	0.0126	CbGeAlD
Sorafenib—UGT1A9—digestive system—duodenum cancer	0.000934	0.0121	CbGeAlD
Sorafenib—RALBP1—pancreas—duodenum cancer	0.000881	0.0114	CbGeAlD
Sorafenib—FLT1—pancreas—duodenum cancer	0.000838	0.0108	CbGeAlD
Sorafenib—FLT3—endocrine gland—duodenum cancer	0.000837	0.0108	CbGeAlD
Sorafenib—MKNK2—digestive system—duodenum cancer	0.000833	0.0108	CbGeAlD
Sorafenib—RAF1—pancreas—duodenum cancer	0.000833	0.0108	CbGeAlD
Sorafenib—MKNK1—digestive system—duodenum cancer	0.000823	0.0107	CbGeAlD
Sorafenib—MAPK11—lymph node—duodenum cancer	0.000818	0.0106	CbGeAlD
Sorafenib—RET—digestive system—duodenum cancer	0.000813	0.0105	CbGeAlD
Sorafenib—CDK7—lymph node—duodenum cancer	0.000805	0.0104	CbGeAlD
Sorafenib—TAOK2—lymph node—duodenum cancer	0.000799	0.0103	CbGeAlD
Sorafenib—AURKC—lymph node—duodenum cancer	0.000792	0.0103	CbGeAlD
Sorafenib—UGT1A9—endocrine gland—duodenum cancer	0.000771	0.00999	CbGeAlD
Sorafenib—FLT4—endocrine gland—duodenum cancer	0.000761	0.00985	CbGeAlD
Sorafenib—RALBP1—digestive system—duodenum cancer	0.000752	0.00974	CbGeAlD
Sorafenib—FLT1—digestive system—duodenum cancer	0.000716	0.00927	CbGeAlD
Sorafenib—RAF1—digestive system—duodenum cancer	0.000712	0.00921	CbGeAlD
Sorafenib—ZAK—lymph node—duodenum cancer	0.000696	0.00901	CbGeAlD
Sorafenib—MKNK2—endocrine gland—duodenum cancer	0.000689	0.00891	CbGeAlD
Sorafenib—HIPK3—lymph node—duodenum cancer	0.000681	0.00881	CbGeAlD
Sorafenib—MKNK1—endocrine gland—duodenum cancer	0.00068	0.0088	CbGeAlD
Sorafenib—STK10—digestive system—duodenum cancer	0.000678	0.00877	CbGeAlD
Sorafenib—RET—endocrine gland—duodenum cancer	0.000672	0.00869	CbGeAlD
Sorafenib—PDGFRA—digestive system—duodenum cancer	0.000671	0.00868	CbGeAlD
Sorafenib—CYP3A7—endocrine gland—duodenum cancer	0.000641	0.0083	CbGeAlD
Sorafenib—UGT1A1—digestive system—duodenum cancer	0.00064	0.00828	CbGeAlD
Sorafenib—TIE1—lymph node—duodenum cancer	0.000636	0.00824	CbGeAlD
Sorafenib—KIT—pancreas—duodenum cancer	0.000628	0.00813	CbGeAlD
Sorafenib—RALBP1—endocrine gland—duodenum cancer	0.000622	0.00805	CbGeAlD
Sorafenib—PDGFRB—pancreas—duodenum cancer	0.000613	0.00794	CbGeAlD
Sorafenib—BRAF—lymph node—duodenum cancer	0.00061	0.0079	CbGeAlD
Sorafenib—KDR—digestive system—duodenum cancer	0.000605	0.00783	CbGeAlD
Sorafenib—FLT1—endocrine gland—duodenum cancer	0.000591	0.00766	CbGeAlD
Sorafenib—CSF1R—digestive system—duodenum cancer	0.00059	0.00764	CbGeAlD
Sorafenib—RAF1—endocrine gland—duodenum cancer	0.000588	0.00761	CbGeAlD
Sorafenib—EPHX2—lymph node—duodenum cancer	0.000583	0.00755	CbGeAlD
Sorafenib—FLT3—lymph node—duodenum cancer	0.000579	0.00749	CbGeAlD
Sorafenib—STK10—endocrine gland—duodenum cancer	0.00056	0.00725	CbGeAlD
Sorafenib—PDGFRA—endocrine gland—duodenum cancer	0.000554	0.00717	CbGeAlD
Sorafenib—KIT—digestive system—duodenum cancer	0.000536	0.00694	CbGeAlD
Sorafenib—UGT1A1—endocrine gland—duodenum cancer	0.000529	0.00684	CbGeAlD
Sorafenib—FLT4—lymph node—duodenum cancer	0.000526	0.00681	CbGeAlD
Sorafenib—PDGFRB—digestive system—duodenum cancer	0.000524	0.00678	CbGeAlD
Sorafenib—FGFR1—lymph node—duodenum cancer	0.000519	0.00672	CbGeAlD
Sorafenib—MAP2K5—endocrine gland—duodenum cancer	0.0005	0.00647	CbGeAlD
Sorafenib—KDR—endocrine gland—duodenum cancer	0.0005	0.00647	CbGeAlD
Sorafenib—MAP3K7—lymph node—duodenum cancer	0.000491	0.00636	CbGeAlD
Sorafenib—ABCC4—pancreas—duodenum cancer	0.000488	0.00632	CbGeAlD
Sorafenib—CSF1R—endocrine gland—duodenum cancer	0.000488	0.00632	CbGeAlD
Sorafenib—MKNK2—lymph node—duodenum cancer	0.000476	0.00616	CbGeAlD
Sorafenib—MKNK1—lymph node—duodenum cancer	0.00047	0.00608	CbGeAlD
Sorafenib—RET—lymph node—duodenum cancer	0.000464	0.00601	CbGeAlD
Sorafenib—KIT—endocrine gland—duodenum cancer	0.000443	0.00574	CbGeAlD
Sorafenib—PDGFRB—endocrine gland—duodenum cancer	0.000433	0.0056	CbGeAlD
Sorafenib—RALBP1—lymph node—duodenum cancer	0.00043	0.00556	CbGeAlD
Sorafenib—ABCC4—digestive system—duodenum cancer	0.000417	0.0054	CbGeAlD
Sorafenib—HTR2B—digestive system—duodenum cancer	0.000415	0.00537	CbGeAlD
Sorafenib—FLT1—lymph node—duodenum cancer	0.000409	0.00529	CbGeAlD
Sorafenib—RAF1—lymph node—duodenum cancer	0.000406	0.00526	CbGeAlD
Sorafenib—EPHB6—lymph node—duodenum cancer	0.000404	0.00523	CbGeAlD
Sorafenib—ABCC2—digestive system—duodenum cancer	0.000404	0.00523	CbGeAlD
Sorafenib—STK10—lymph node—duodenum cancer	0.000387	0.00501	CbGeAlD
Sorafenib—PDGFRA—lymph node—duodenum cancer	0.000383	0.00496	CbGeAlD
Sorafenib—CYP2C19—digestive system—duodenum cancer	0.000347	0.00449	CbGeAlD
Sorafenib—KDR—lymph node—duodenum cancer	0.000346	0.00447	CbGeAlD
Sorafenib—MAP2K5—lymph node—duodenum cancer	0.000346	0.00447	CbGeAlD
Sorafenib—ABCC4—endocrine gland—duodenum cancer	0.000345	0.00446	CbGeAlD
Sorafenib—CSF1R—lymph node—duodenum cancer	0.000337	0.00437	CbGeAlD
Sorafenib—ABCC2—endocrine gland—duodenum cancer	0.000334	0.00432	CbGeAlD
Sorafenib—CYP3A5—pancreas—duodenum cancer	0.00032	0.00414	CbGeAlD
Sorafenib—KIT—lymph node—duodenum cancer	0.000306	0.00396	CbGeAlD
Sorafenib—PDGFRB—lymph node—duodenum cancer	0.000299	0.00387	CbGeAlD
Sorafenib—CYP2C19—endocrine gland—duodenum cancer	0.000287	0.00371	CbGeAlD
Sorafenib—CYP1A2—digestive system—duodenum cancer	0.000283	0.00367	CbGeAlD
Sorafenib—CYP3A5—digestive system—duodenum cancer	0.000273	0.00354	CbGeAlD
Sorafenib—CYP2B6—digestive system—duodenum cancer	0.000272	0.00352	CbGeAlD
Sorafenib—CYP2C9—digestive system—duodenum cancer	0.000269	0.00348	CbGeAlD
Sorafenib—CYP2C8—endocrine gland—duodenum cancer	0.00025	0.00324	CbGeAlD
Sorafenib—ABCC4—lymph node—duodenum cancer	0.000238	0.00308	CbGeAlD
Sorafenib—HTR2B—lymph node—duodenum cancer	0.000237	0.00307	CbGeAlD
Sorafenib—CYP1A2—endocrine gland—duodenum cancer	0.000234	0.00303	CbGeAlD
Sorafenib—ABCC2—lymph node—duodenum cancer	0.000231	0.00298	CbGeAlD
Sorafenib—CYP3A5—endocrine gland—duodenum cancer	0.000226	0.00292	CbGeAlD
Sorafenib—CYP2B6—endocrine gland—duodenum cancer	0.000224	0.0029	CbGeAlD
Sorafenib—CYP2C9—endocrine gland—duodenum cancer	0.000222	0.00288	CbGeAlD
Sorafenib—CYP3A4—digestive system—duodenum cancer	0.000205	0.00265	CbGeAlD
Sorafenib—CYP2D6—digestive system—duodenum cancer	0.000202	0.00261	CbGeAlD
Sorafenib—ABCB1—pancreas—duodenum cancer	0.00017	0.0022	CbGeAlD
Sorafenib—CYP3A4—endocrine gland—duodenum cancer	0.000169	0.00219	CbGeAlD
Sorafenib—ABCG2—lymph node—duodenum cancer	0.000168	0.00218	CbGeAlD
Sorafenib—CYP2D6—endocrine gland—duodenum cancer	0.000167	0.00216	CbGeAlD
Sorafenib—ABCB1—digestive system—duodenum cancer	0.000145	0.00188	CbGeAlD
Sorafenib—ABCB1—endocrine gland—duodenum cancer	0.00012	0.00155	CbGeAlD
Sorafenib—ABCB1—lymph node—duodenum cancer	8.29e-05	0.00107	CbGeAlD
